Compare SOHU & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOHU | CYRX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | China | United States |
| Employees | N/A | 1100 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.6M | 419.3M |
| IPO Year | 2018 | 2008 |
| Metric | SOHU | CYRX |
|---|---|---|
| Price | $15.66 | $12.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $20.00 | $13.31 |
| AVG Volume (30 Days) | 68.9K | ★ 478.6K |
| Earning Date | 05-18-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $1.61 | $11.06 |
| Revenue Next Year | $3.78 | $8.45 |
| P/E Ratio | ★ $1.16 | $8.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.53 | $5.31 |
| 52 Week High | $17.30 | $12.65 |
| Indicator | SOHU | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 77.57 |
| Support Level | $15.02 | $7.98 |
| Resistance Level | $16.13 | N/A |
| Average True Range (ATR) | 0.45 | 0.58 |
| MACD | 0.05 | 0.16 |
| Stochastic Oscillator | 73.64 | 87.96 |
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.